| Metric | Q2'26 | Q3'26 | Change |
|---|---|---|---|
| Net Sales | $1.0B, +37% YoY | $1.2B, +60% YoY | Record quarter, growth accelerating |
| Non-GAAP EPS | $0.99 | $1.46 | +47% sequential beat |
| GAAP Operating Income | $109.1M | $162.3M | +49% sequential |
| Adjusted EBITDA Margin | 16.6% | 20.1%, +350bps sequential | Sharp margin inflection |
| Gross Margin | 21.9% | 24.8% | +290bps sequential |
| A&D % of Sales / YoY Growth | 37% of sales, +14% YoY | 34% of sales, +21% YoY | Mix shrinking but growth accelerating |
| A&D Backlog | $1.7B, up from $1.5B YoY | $2.0B record, up from $1.5B YoY | +18% sequential to record |
| DCN % of Sales / YoY Growth | 40% of sales, +91% YoY, Q3 guided to 49% | 41% of sales, +115% YoY, actual vs 49% guide | Missed prior guide by ~800bps of mix |
| N+M as % of DCN | Not disclosed as a %; dollar guide of $200M Q3/$400M Q4 | ~30% of DCN now, rising to ~50% in 2027 | Metric switched from $ to %, dollar figures internally inconsistent this quarter |
| Overall Book-to-Bill | 1.49 | 2.1 | Dramatic acceleration |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.